Bovine Milk Exosomes: A Game-Changer in Melanoma Therapy?

Melanoma remains one of the most aggressive and treatment-resistant cancers. Traditional chemotherapy agents, such as dacarbazine (DTIC), present serious dose-dependent toxicities and limited efficacy, calling for novel drug delivery strategies. A recent study published in Drug Delivery and Translational Research (2025) by Ashish Agrawal explores the potential of bovine milk extracellular vesicles for oral drug delivery in melanoma therapy.

Key Findings from the Study:

📌 Superior Drug Loading & Stability

• Exosomes were isolated from bovine milk using ultracentrifugation, then loaded with Dihydroartemisinin (DHA), an anti-cancer compound, via sonication.
• The resulting Exo-DHA had a high drug entrapment efficiency (73.9%) and demonstrated optimal particle size (~103 nm), zeta potential (-27.4 mV), and stability.

📌 Enhanced Anti-Cancer Activity

• Compared to free DHA, Exo-DHA reduced melanoma cell viability significantly in B16F10 cell assays. The IC50 dropped from 37.4 μM (DHA) to 16.9 μM (Exo-DHA) after 72 hours, demonstrating superior cytotoxicity.
• Western blot analysis confirmed increased expression of pro-apoptotic proteins (Bax) and decreased levels of anti-apoptotic/metastatic proteins (Bcl-2, Survivin, MMP-9).

📌 Improved Oral Bioavailability

• Exo-DHA exhibited a 2.8-fold increase in bioavailability compared to free DHA, overcoming DHA’s poor solubility and rapid clearance.
• Tissue distribution studies revealed reduced liver accumulation, lowering toxicity while ensuring efficient systemic circulation.

📌 In Vivo Efficacy & Reduced Metastasis

• In melanoma-bearing mice, Exo-DHA achieved an 83.2% tumor growth inhibition, outperforming free DHA (63.5%) and DTIC (71.2%).
• Metastasis suppression was significantly enhanced, with fewer lung nodules in Exo-DHA-treated groups compared to DHA and DTIC.

This research underscores bovine milk exosomes’ potential as a natural, scalable, and effective drug delivery platform for melanoma therapy. Could milk-derived EVs be the future of cancer treatment?

🔗 Read the full study: https://link.springer.com/article/10.1007/s13346-024-01785-6